COVID vaccines induce robust protection against severe disease from Omicron
The research demonstrated that the vaccines induce this protection through cellular immunity or the production of protective…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
Zydus supplies the first consignment of its COVID-19 vaccine ZyCoV-D
ZyCoV-D is a three-dose vaccine administered intradermally using the painless PharmaJet needle-free system, Tropis, on day zero,…
Trial tests strategy to augment response to COVID-19 vaccines in transplant recipients
The clinical trial will enroll people for whom two-to-four doses of a COVID-19 mRNA vaccine did not elicit a detectable antibody…
Moderna starts trial for Omicron-specific booster shot
The company said while a third shot of its original coronavirus vaccine increased neutralising antibodies against the variant at…
EU drug regulator OKs Pfizer COVID pill for high-risk patients
The endorsement by EMA for a conditional approval, if followed as usual by the European Commission, allows EU member states to…
DCGI approves “Conditional Market Authorisation” of Covaxin and Covishield
The approval pathways through this route are fast-tracked with certain conditions to enhance the access to certain pharmaceuticals…
Mix-and-match trial finds additional dose of COVID-19 vaccine safe and immunogenic
All combinations of primary and booster vaccine resulted in increased neutralising antibody levels (ranging from 4.2- to 76-fold…
Israel broadens eligibility for fourth shot of COVID vaccine
Earlier this month, Israel began offering the fourth jab to people over 60, on the condition that at least five months have passed…
Each dose of Covishield and Covaxin likely to be capped at Rs 275 after getting regular market…
National Pharmaceutical Pricing Authority (NPPA) has been directed to start working towards capping the price to make the vaccines…
‘Nocebo effect’ behind two-thirds of COVID vax side effects: Study
The "nocebo effect" occurs when a person experiences unpleasant side effects after taking a treatment with no pharmacological…
US limits use of Regeneron and Eli Lilly COVID-19 antibody treatments amid Omicron spread
The Food and Drug Administration (FDA) said the treatments are currently not cleared for use in any US states or territories, but…
Omicron may not evade all monoclonal antibodies, lab study suggests
Several past studies have shown that such antibodies are unsuccessful in neutralising Omicron
Three doses of mRNA COVID vaccines very effective against Omicron and Delta: Study
The study, from the US Centers for Disease Control and Prevention (CDC), found that boosters of mRNA COVID vaccines are 82 per…
Moderna vax may lead to fewer breakthrough COVID infections than Pfizer
A research, published in the Journal of the American Medical Association, found those who received the Moderna vaccine were less…
Chung-Ang University researchers show gold-paved path towards faster COVID-19 diagnosis
Researchers use gold nanoparticles to develop a new molecular diagnostic platform that considerably reduces the time required for…
SMS Pharmaceuticals receives non-exclusive licence to manufacture and supply Molnupiravir through…
The step has been taken to increase broad access of COVID-19 treatment in 105 Low- and Middle- Income Countries (LMICs)
Biophore receives sub-licence from MPP to manufacture and market Molnupiravir
The company has received DCGI regulatory license for the Indian market, applicable for both API as well as the finished product
Fermenta Biotech licenses its proprietary enzymatic technology for manufacturing Molnupiravir to…
Fermenta has signed a definitive agreement with Aurigene, a stepdown subsidiary of Dr Reddy’s Laboratories
Sputnik V demonstrates strong protection against Omicron variant
Previous studies also demonstrated additional significant strengthening of protection against Omicron by Sputnik Light…
Bill & Melinda Gates Foundation and Wellcome pledge $300 million to CEPI for COVID-19 pandemic…
The foundations call on world leaders to support the Coalition for Epidemic Preparedness Innovations (CEPI) to help end the…